Cargando…

Clopidogrel-Induced Eosinophilic Colitis

Eosinophilic colitis is a rare condition characterized by histologic findings of high eosinophilic infiltrate in the gut wall, typically presenting with diarrhea and abdominal pain. The etiology of this entity remains unclear because it can be primary or can occur secondarily to infections, drugs, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djahandideh Sheijani, Shirin, Calabrese, Francesco, Pasta, Andrea, Marabotto, Elisa, Bodini, Giorgia, Furnari, Manuele, Grillo, Federica, Mastracci, Luca, Savarino, Edoardo V., Savarino, Vincenzo, Giannini, Edoardo G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400044/ https://www.ncbi.nlm.nih.gov/pubmed/37547482 http://dx.doi.org/10.14309/crj.0000000000001118

Ejemplares similares

Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease
por: Savarino, Edoardo, et al.
Publicado: (2014)

Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose
por: Marabotto, Elisa, et al.
Publicado: (2022)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review
por: Marabotto, Elisa, et al.
Publicado: (2022)

Prevention Strategies for Esophageal Cancer—An Expert Review
por: Marabotto, Elisa, et al.
Publicado: (2021)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

The Lyon Consensus: Does It Differ From the Previous Ones?
por: Ghisa, Matteo, et al.
Publicado: (2020)

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy
por: Bagnasco, Diego, et al.
Publicado: (2023)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease
por: Savarino, Edoardo, et al.
Publicado: (2017)

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
por: Plaz Torres, Maria Corina, et al.
Publicado: (2019)

Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

A More In-depth Evaluation of Impedance-pH Could Assist in Distinguishing Reflux-related From Reflux-unrelated Heartburn
por: de Bortoli, Nicola, et al.
Publicado: (2015)

Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care
por: Bozzani, Alberto, et al.
Publicado: (2020)

Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors
por: Tolone, Salvatore, et al.
Publicado: (2016)

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
por: Savarino, Vincenzo, et al.
Publicado: (2021)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature
por: Ghisa, Matteo, et al.
Publicado: (2022)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak
por: Savarino, Edoardo, et al.
Publicado: (2020)

Distinction between patients with non-erosive reflux disease and functional heartburn
por: Giacchino, Maria, et al.
Publicado: (2013)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis and GERD: links and risks
por: Ghisa, Matteo, et al.
Publicado: (2019)

Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak
por: Savarino, Edoardo Vincenzo, et al.
Publicado: (2020)

A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis
por: Massimino, Luca, et al.
Publicado: (2023)

Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn
por: Martinucci, Irene, et al.
Publicado: (2018)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
por: Marasco, Giovanni, et al.
Publicado: (2023)

Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
por: Ribolsi, Mentore, et al.
Publicado: (2021)

Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

Gastrointestinal Tract Cancers, an Increasing Burden of the Modern Era: Epidemiology and Prevention
por: Kayali, Stefano, et al.
Publicado: (2023)

Starry Liver: An Unexpected Diagnosis
por: Del Nero, Lorenzo, et al.
Publicado: (2015)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions
por: Businello, Gianluca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9mru0nfunjiooaruebb08mih6